1. Structure–activity study of the actions of camptothecin derivatives on mammalian topoisomerase I: evidence for a specific receptor site and for a relation to antitumor activity;Jaxel;Cancer Res.,1989
2. Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins;Carbonero;Clin. Cancer Res.,2002
3. Camptothecins: a review of their development and schedules of administration;O'Leary;Eur. J. Cancer,1998
4. Phase I study and pharmacokinetics of CPT-11 with 5-day continuous infusion;Ohe;J. Natl. Cancer Inst.,1992
5. Metabolic fate of Irinotecan in humans: correlation of glucuronidation with diarrhea;Gupta;Cancer Res.,1994